1991). Self-assessment of the presence and type of cervicovaginal fluid (CVF) at the vulva forms the basis of family The aim of this study was to assess how effectively the Rovuplanning by avoiding sexual intercourse during the PPF [World meter™, designed for the volumetric self-sampling of cervHealth Organization (WHO), 1981a,b] . The failure rate of this icovaginal fluid (CVF), can be used to locate the minimum method expressed as typical use is~20% and 1-3% for period of potential fertility (PPF) during ovulatory cycles. A perfect use (Hatcher et al., 1994) . These data suggest that the multicentre, prospective study was undertaken of volunteers development of a test based on the measurement of a distinct (attending natural family planning clinics) over three consecchange in CVF might improve the general acceptance and utive, apparently normal, menstrual cycles. All women colpractice of this approach to family planning. lected daily samples of early morning urine and CVF and
The volume and viscoelasticity of CVF are related variables recorded the volumes (to the nearest 1.0 and 0.1 ml respectwhich tend to increase during follicular development and ively). The concentrations of oestrone glucuronide (EG), decrease in the immediate postovulatory phase of the menstrual luteinizing hormone (LH) and pregnanediol glucuronide cycle (Viergiver and Pommerenke, 1946; Wolf et al., 1978) . (PG) were measured in all samples of early morning urine However, initial attempts to use systematic changes in the by immunoassay. A preliminary data set was used to optimize volume of CVF to locate the PPF were unsuccessful (Moghissi, an algorithm to detect the start and end of potential fertility 1979; Wagner, 1979) , and might be explained by the use of from the volumes of CVF. The end-points used were the tampons to collect the samples (Godley, 1985) . The developnormality of each menstrual cycle from its length, the length ment of a small, graduated aspirator (the Rovumeter™) has of luteal phase, and concentrations of EG, LH and PG, the enabled women to take and read the volume of a daily start and end days of potential fertility from CVF volumes, sample of their CVF under standardized conditions (Usala and and the minimum PPF, which was defined as the day of the Schumacher, 1983) . Preliminary data from the use of this LH peak minus 3 to day plus 2 inclusive. Overall, 72 women device by experienced users of the symptothermal method of (median age 30 years, range 24-38) were recruited from natural family planning have shown that changes in the volume three centres (23 from Birmingham, 24 from Milan, 25 from of CVF might be used to develop an algorithm to predict Santiago) and contributed data from 235 menstrual cycles ovulation and the start and end of potential fertility (Flynn (median length 28 days, range 23-44). The urinary LH peak et al., 1988a,b) . was identified in 228 cycles (97%; median time, day 15 from
We now report the main findings from a multicentre study day 1 of last menses, with range day 10 to day 35). The use designed to provide information about the potential value of of the Rovumeter™ gave start and end signals of potential using the Rovumeter™ to locate the minimum PPF (as defined fertility during 138 cycles (59% The aim was to study the use and acceptability of the Rovumeter™ in three centres located in different countries with laboratory facilities changes in the volume of CVF as determined by the use of for the measurement of hormone metabolites in urine (Birmingham, wall; (v) aspirate with the right hand while maintaining the device firmly in position with the left hand; (vi) ensure that all the fluid is UK; Milan, Italy; Santiago, Chile). The plan was to recruit 25 women of reproductive age from each centre and study three consecutive removed by gently moving the aspirator from side to side as the plunger is withdrawn to the maximum; (vii) hold the aspirator menstrual cycles. Established indices of hormone production were to be used to define minimum periods of potential fertility (Collins et al., vertically with the end uppermost and expel air by gently pressing the plunger; (viii) read volume of fluid to the nearest 0.1 ml. All 1979; WHO, 1982 WHO, , 1983a . After the last day of menses, all volunteers were to: (i) take a daily sample of their CVF with the Rovumeter™ volunteers were given personal instruction by an experienced user of the device. and record the volume, (ii) collect a daily sample of early morning urine (for the subsequent analysis of urinary hormone metabolites)
Urinary hormone immunoassay and record the time since last urination and volume, (iii) record traditional signs of potential fertility on a symptothermal chart, and
The frozen urine samples were collected from each volunteer by the Chart Co-ordinator and taken to a local laboratory for the analysis of (iv) complete a questionnaire for assessing the acceptability of the device. Data from items (iii) and (iv) would only be processed if the oestrone glucuronide (EG), luteinizing hormone (LH) and pregnanediol glucuronide (PG) by non-competitive radioimmunoassays. The results from items (i) and (ii) for the whole study were sufficiently encouraging.
reagents and assay protocols were supplied by the Matched Reagents Programme of the WHO (Queen Charlottes and Chelsea Hospitals, The project co-ordinator (A.M.F.) was located in Birmingham. All centres had a Principal Investigator and a Chart Co-ordinator and Goldhawk Road, London, UK). The results for this aspect of the study were expressed as nmol/l for EG, U/l for LH, and µmol/l for followed the same protocol (including the use of identical report forms).
PG. Each laboratory implemented their own internal quality control procedures and participated in a programme of external quality Criteria for subject selection assessment coordinated by the London centre mentioned above. The volunteers had to be experienced users of the symptothermal Definitions method of natural family planning and had to fulfil the following
The following definitions were used: (i) day 1 of cycle: the first day criteria: (i) be aged between 25 and 39 years inclusive (the study of menstruation (the day starting after midnight on which there is an period had to finish before the 40th birthday), (ii) have regular appreciable flow of blood through the vagina), (ii) last day of cycle: menstrual cycles (length 25-35 days for the last six cycles), (iii) have the day previous to day 1 of next cycle, (iii) a normal menstrual a symptothermal chart for the last cycle which illustrated a PPF, (iv) cycle: a cycle with sequential changes in the concentrations of urinary not have used any form of hormonal contraception or intrauterine EG, LH and PG, which are consistent with a PPF, (iv) peak day of device for the previous six cycles and not have an intention of using urinary LH: the day with the highest numerical value for LH between such methods of contraception during the study period, (v) have no days 10 and 35 of the cycle with an appropriate temporal relationship history or evidence of liver or kidney disease or dysfunction (which to the rise and fall in the concentration of EG and the rise in the might affect the urinary excretion of hormone metabolites), nor any concentration of PG, (v) the minimum PPF: the day of the LH recent pathological discharge from the vagina, (vi) not be receiving peak minus 3 to day plus 2 inclusive, (vi) a signal: the indicator of any form of chronic drug therapy, (vii) not be working night shifts, the start of the PPF or infertile period, and (vii) length of PPF: the (viii) not planning a pregnancy during the study period, (ix) be willing day of the start signal to day of signal for infertile period minus 1. to make daily aspirates of their CVF and record the volumes on a diary sheet, (x) be willing to collect daily timed and measured samples Data analysis of early morning urine (and store them for a limited period in their
The clinical report forms from all centres were sent to the Project freezer), (xi) be willing to record the signals of the symptothermal Co-ordinator for checking before entry into a computer by a Data method on a diary sheet, and (xii) be willing to provide information Entry Clerk. The data were rechecked and analysed by P.R. Initially, on when barrier methods of contraception or spermicides were used plots were made of the concentrations of urinary EG, LH and PG for during the study period.
each volunteer by day of cycle for visual inspection of normality. Similarly, the volumes of CVF for each woman for all three cycles Cervicovaginal fluid aspiration were plotted on the same graph, and then combined by centre A disposable, sterile, plastic volumetric aspirator (the Rovumeter™; and overall. A & O Pharmavertries, Munich, Germany) was used to make the daily collection of CVF from the upper vagina and posterior fornix.
Optimization of algorithm A set of preliminary rules to determine signals for the start and end The aspirator is a graduated, syringe-like device (135 mm in length) with a blunt, bulb-headed, flat, elliptically shaped mouthpiece with of a PPF were kindly supplied by Dr G.F.B.Schumacher (Department of Obstetrics and Gynecology, The University of Chicago Pritzer an outer gutter. The inner diameter of the bulb head is 5 mm. A photograph of the device has been published (Flynn et al., 1988a,b) .
School of Medicine, Chicago, IL, USA). These rules were adapted slightly for electronic data processing, and optimized by application The sampling time was chosen by the individual women (in the morning before any act of intercourse) and used consistently for a to a preliminary data set (mainly to improve the number and timing of start signals for the infertile period). complete menstrual cycle. Instructions for using the device have been published (Usula and Schumacher, 1983) . Briefly, each volunteer was
The finalized algorithm was as follows: (i) identify the highest value (max) for the volume of CVF from the first three recorded told to: (i) hold the aspirator so that the opening is directed towards the vagina with the largest diameter of the bulb in a horizontal values (if all three values are the same, add 0.05 ml to max); (ii) the first of the following days when the volume is greater than or equal position and the longitudinal gutter on the upper side; (ii) determine the most convenient position to use the device (standing, sitting or to max is the signal (day) for the start of a PPF. The volume must increase to greater than max ϩ 0.25 ml then decrease for a signal to lying on the back); (iii) gently insert the aspirator along the posterior wall of the vagina until it will go no further (ensuring that it is behind occur for the start of the infertile period. The second consecutive day of values less than or equal to max ϩ 0.25 ml is noted and the fourth the lips of the cervix/neck of the womb); (iv) withdraw the aspirator slowly so that movement of the plunger does not suck up the vaginal day after that day is the signal (day) for the start of the infertile period. were similar at each centre. The number of samples of CVF that were tested ranged from 8 to 29 (median 14).
Results
Success rates A total of 72 women were recruited; 58 (81%) provided data from three consecutive cycles (one, nine, two and two women
The number (and percentage) of successful tests per cycle, i.e. provided data from two, four, five and six consecutive cycles where signals for the start and end of the PPF covered the respectively). Overall, 235 cycles were studied and 228 (97%) defined minimum PPF, are shown by centre and overall in had an identifiable peak of urinary LH. The contribution of Table IV . Overall, the test was successful in 113/228 cycles data from each centre and some characteristics of the menstrual (50%) and the value ranged from 28% at Milan to 62% at cycles are shown in Table I . There was no significant difference Birmingham. between the three centres for the age of the volunteers, the The number of women in whom the test was successful or length of the cycles, the day of the urinary LH peak or the unsuccessful over three consecutive cycles is shown in Table V . length of the luteal phase.
Overall, the test was successful in 15/71 (21%) of women and unsuccessful in 20/71 (28%). The success rates were 32, 8 Volume of CVF and 24% at Birmingham, Milan and Santiago respectively. The number of CVF volumes that was recorded by day of
The relationship between the successful use of the test (by cycle is shown, by centre, in Figure 1 . There was a gradual women from Birmingham and Santiago) and the mean volume increase in the number of observations at all centres until day of CVF for days 10-18 over consecutive menstrual cycles is 8 and a corresponding reduction around day 25. The volume shown in Table VI . The mean (SD) volume of CVF associated of CVF by day relative to the day of the urinary LH peak with successful use, 0.37 (0.17), was significantly higher (day 0), by centre, is shown in Figure 2 . The median values (P Ͻ 0.001, Student's t-test) than the corresponding value, on day 0 were 0.187 ml for Milan, 0.375 ml for Santiago and 0.20 (0.13), associated with unsuccessful use. 0.438 ml for Birmingham.
Time of signals Discussion
A preliminary testing of the Rovumeter at one centre The number of start and end signals for the PPF relative to day 1 of menses and the day of the urinary LH peak are shown (Birmingham) had indicated that serial changes in the volume of CVF reflect oestrogenic activity and the values might in Table II . Overall, there were 226 start signals from 235 cycles (96%), but only 138 end signals (59%). Seven cycles therefore be used in a refined algorithm to delineate the PPF during a normal menstrual cycle (Flynn et al., 1988a,b) . The did not have a urinary LH peak; of those that did, 99% had a start signal and 61% an end signal for the PPF. The mean (and findings were sufficiently encouraging to initiate a multicentre study designed to provide additional and complementary data median) day for the start signal was day of urinary LH peak minus 5; the corresponding day for the end signal was over consecutive menstrual cycles from different groups of women, who were experienced users of the symptothermal day of urinary LH peak plus 3. of urinary EG, LH and PG were used as additional indices to assess the normality of each study cycle. The day of the LH meter. This algorithm was optimized by a systematic evaluation of the rules when applied to a subset of the data acquired from peak was used as a reference point for impending ovulation and the minimum PPF (Collins, 1989) . the multicentre study. The principal aim was to improve the number and timing of the 'off' signals without compromising Alternative algorithms for identifying the PPF have been reviewed (Royston, 1991) . Initially, cumulative sum (CUSUM) the number and timing of the 'on' signals and the length of the derived PPF. analysis with a peak selecting algorithm was applied to CVF volumes to determine the start and end of a PPF (Flynn et al., The main findings were firstly that the test only covered the minimum PPF in 50% of cycles, and secondly that only 1988b). This approach failed to produce an appropriate end signal in 50% of 16 cycles where the day of maximum 21% of women had a consistently successful test result over three consecutive cycles. There were, however, considerable follicular diameter (as determined by pelvic ultrasonography) was used as the reference point for ovulation and potential differences in the success rates between centres (i.e. the success rate per cycle varied between 28% at Milan and 62% at fertility. Accordingly, a computer programme was written for a manual algorithm developed by the designer of the RovuBirmingham, and the success rate per woman for three cycles days of the menstrual cycle (see Figure 1) . The success rate of the test was undoubtedly related to the mean volume of CVF produced by each woman over days type (or consistency) of CVF is more important than the volume (Odeblad, 1977 has been reported (Wolf et al., 1980; Van Koij et al., 1980;  All (%) 20 (28) 36 (51) 15 (21) 71 (100) Tsibris et al., 1989) . Consequently, a test that is based on a physicochemical characteristic of mucus (e.g. viscosity), or a a One woman provided data for two cycles only.
ratio of two constituents (e.g. an enzyme/total protein), or the degree of hydration is likely to be more successful than volume varied between 8% at Milan and 32% at Birmingham. These findings might simply reflect differences in small, self-selected in delineating the PPF. The Rovumeter is undoubtedly cheap and useful for a small groups of women. Alternatively, the values might indicate real
